Berit Jul Mosgaard

3PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 21, 2022
Residual tumor and primary debulking surgery vs interval debulking surgery in stage IV epithelial ovarian cancer.

Sarah Mejer Sørensen, Claus Høgdall, Berit Jul Mosgaard

|Nov 13, 2020
Prognostic utility of serum YKL-40 in patients with cervical cancer.

Anne Roslind, Connie Palle, Julia Sidenius Johansen

|Feb 07, 2020
Risk factors for early death among ovarian cancer patients: a nationwide cohort study.

Berit Jul Mosgaard, Amani Meaidi, Claus Høgdall

Pageof 1